Document Detail


Reduction in 28 Days and 6 Months of Acute Myocardial Infarction Mortality From 1995 to 2005. Data From PRIAMHO I, II and MASCARA Registries.
MedLine Citation:
PMID:  21803474     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
INTRODUCTION AND OBJECTIVES: To determine whether mortality from acute myocardial infarction has reduced in Spain and the possibly related therapeutic factors. METHODS: Nine thousand, nine hundred and forty-nine patients with ST-segment elevation myocardial infarction admitted to the Coronary Care Unit were identified from PRIAMHO I, II and MASCARA registries performed in 1995, 2000 and 2005, with a 6 month follow-up. RESULTS: From 1995 to 2005 patients were increasingly more likely to have hypertension, hyperlipidemia and anterior infarction, but age of onset and the proportion of females did not increase. Twenty-eight-day mortality rates were 12.6%, 12.3% and 6% in 1995, 2000 and 2005 respectively, and 15.3%, 14.6% and 9.4% at 6 months (both P-trend <.001). Multivariate analysis was performed and the adjusted odds ratio for 28-day mortality for an infarction occuring in 2005 (compared with 1995) was 0.62 (95% confidence interval: 0.44-0.88) whereas the adjusted hazard ratio for mortality at 6 months was 0.40 (95% confidence interval: 0.24-0.67). Other variables independently associated with lower mortality at 28 days were: reperfusion therapy, and the use of anti-thrombotic treatment, beta-blockers and angiotensin-converting enzyme inhibitors. The 28-day-6-month period had an independent protective effect on the following therapies: coronary reperfusion, and prescription of antiplatelet agents, beta-blockers and lipid lowering drugs upon discharge. CONCLUSIONS: Twenty-eight-day and six-month mortality rates fell among patients with ST-elevation myocardial infarction in Spain from 1995 to 2005. The possibly related therapeutic factors were the following: more frequent reperfusion therapy and increased use of anti-thrombotic drugs, beta-blockers, angiotensin-converting enzyme inhibitors and lipid lowering drugs. Full English text available from: www.revespcardiol.org.
Authors:
Fernando Arós; Magda Heras; Joan Vila; Héctor Sanz; Ignacio Ferreira-González; Gaietà Permanyer-Miralda; José Cuñat; Lorenzo López-Bescós; Adolfo Cabadés; Angel Loma-Osorio; Jaume Marrugat;
Related Documents :
14503934 - Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart fail...
25276294 - Thrombus aspiration in acute myocardial infarction: rationale and indication.
17868954 - Beyond pulmonary edema: diagnostic, risk stratification, and treatment challenges of ac...
3022514 - Why are the angiotensin converting enzyme inhibitors rational in the treatment of conge...
16766634 - Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloprot...
7053604 - Role of catheter mapping in the preoperative evaluation of ventricular tachycardia.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-7-29
Journal Detail:
Title:  Revista espanola de cardiologia     Volume:  -     ISSN:  1579-2242     ISO Abbreviation:  -     Publication Date:  2011 Jul 
Date Detail:
Created Date:  2011-8-1     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0404277     Medline TA:  Rev Esp Cardiol     Country:  -    
Other Details:
Languages:  ENG; SPA     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.
Affiliation:
Servicio de Cardiología, Hospital Txagorritxu, José Atxotegi, s/n, 01009 Vitoria-Gasteiz, Álava, España.
Vernacular Title:
Reducción de la mortalidad precoz y a 6 meses en pacientes con IAM en el periodo 1995-2005. Datos de los registros PRIAMHO I, II y MASCARA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Fat grafting in facial burns sequelae.
Next Document:  Activities during interruptions in cardiopulmonary resuscitation: A simulator study.